32°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
News
- Local News
- State News
Sports
- Local Sports
- Pro Sports
Lifestyle
- Local Entertainment
Multimedia
Community Choice
Features
Classifieds
- Place Ad
- Legal Notices
Public Notices
Obituaries
E-Edition
STOCKING STUFFER CONTEST

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NeoGenomics, Inc. - Common Stock (NQ:NEO)

11.78 -0.45 (-3.68%)

Streaming Delayed Price Updated: 3:42 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about NeoGenomics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care

March 22, 2023

From Massive Bio, Inc.

Via Business Wire

3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing ↗

March 19, 2023

The high-flyers have soared to new heights and further gains could be up ahead.

Via The Motley Fool

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

March 16, 2023

Via ACCESSWIRE

NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP

March 13, 2023

Via ACCESSWIRE

Analyst Ratings for NeoGenomics ↗

March 03, 2023

Via Benzinga

Cowen & Co. Maintains Outperform Rating for NeoGenomics: Here's What You Need To Know ↗

February 24, 2023

Via Benzinga

Why Shares of NeoGenomics Jumped Today ↗

February 23, 2023

The company released promising earnings results.

Via The Motley Fool

NeoGenomics to Present at the 44th Annual Raymond James Institutional Investors Conference

February 28, 2023

Via ACCESSWIRE

Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023 ↗

February 24, 2023

Via Benzinga

Crude Oil Rises 1.5%; NeoGenomics Shares Spike Higher ↗

February 23, 2023

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded down 0.03% to 33,036.50 while the NASDAQ rose 0.46% to...

Via Benzinga

Why NeoGenomics Shares Are Trading Higher Today ↗

February 23, 2023

Via Benzinga

NeoGenomics Reports Fourth Quarter and Full Year 2022 Results

February 23, 2023

Via ACCESSWIRE

Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 23, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 23, 2023

Via Benzinga

US Stocks Turn Lower; Dow Drops 150 Points ↗

February 23, 2023

U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Thursday. The Dow traded down 0.47% to 32,889.30 while the NASDAQ fell 0.47% to 11,452.63. The S&P 500...

Via Benzinga

Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday ↗

February 23, 2023

U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of NeoGenomics Laboratories, Inc. (NEO) Investigation

February 08, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

NeoGenomics, Inc. (NASDAQ:NEO) Investor Notice: Deadline in Lawsuit on February 6, 2023 ↗

February 06, 2023

San Diego, CA -- (SBWIRE) -- 02/06/2023 -- The Shareholders Foundation announced that a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of NeoGenomics, Inc....

Via SBWire

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

NEO FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO

February 06, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Notifies NeoGenomics, Inc. (NEO) Investors of Class Action and to Actively Participate

February 06, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

NeoGenomics Schedules its Fourth Quarter and Full Year 2022 Earnings Release for February 23, 2023

February 06, 2023

Via ACCESSWIRE

RaDaR(R) Assay Demonstrates Clinical Potential for Helping Oncologists Determine Whether or Not Muscle-Invasive Bladder Cancer Patients Undergo Radical Surgery

February 06, 2023

Via ACCESSWIRE

NEO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages NeoGenomics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO

February 04, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NEOGENOMICS 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess Of $100,000 of Deadline in Class Action Lawsuit Against NeoGenomics, Inc. - NEO

February 03, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

NEOGENOMICS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NeoGenomics, Inc. and Encourages Investors to Contact the Firm

February 03, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against F45 Training, Silvergate, NeoGenomics, and Iris and Encourages Investors to Contact the Firm

February 03, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NeoGenomics, Inc. (NEO)

February 03, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

NEO FINAL DEADLINE NOTICE: ROSEN, A LEADING AND RANKED FIRM, Encourages NeoGenomics, Inc. Investors with Losses to Secure Counsel Before Important February 6 Deadline in Securities Class Action - NEO

February 02, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Fraud Lawsuit

Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023 ↗

February 01, 2023

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Multimedia
Local Events
Classifieds
Obituaries
Weather
Online Features

Services

About Us
Contact Us
Promote Your Event
Subscriber Services
Online Forms
Rack Locations

woonsocketcall.com
Address: 154 Main Street
Woonsocket, RI 02895
Phone: 401-762-3000
Email: notices@woonsocketcall.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

NeoGenomics, Inc. - Common Stock (NQ:NEO)

All News about NeoGenomics, Inc. - Common Stock

Sections

Services